Simon Quick Advisors, LLC Gilead Sciences, Inc. Transaction History

Simon Quick Advisors, LLC

$1.57 Billion
Q3 2024

A detailed history of Simon Quick Advisors, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Simon Quick Advisors, LLC holds 4,906 shares of GILD stock, worth $433,690. This represents 0.03% of its overall portfolio holdings.

Number of Shares

4,906

Previous 3,390 44.72%

Holding current value

$433,690

Previous $232,000 77.16%

% of portfolio

0.03%

Previous 0.02%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	BUY	$66.59 - $83.99 $100,950 - $127,328	1,516 Added 44.72%	4,906 $411,000
Q2 2024 Aug 02, 2024	BUY	$63.15 - $72.88 $21,660 - $24,997	343 Added 11.26%	3,390 $232,000
Q1 2024 Apr 19, 2024	BUY	$71.58 - $87.29 $9,162 - $11,173	128 Added 4.39%	3,047 $223,000
Q4 2023 Jan 16, 2024	SELL	$73.27 - $83.09 $90,928 - $103,114	-1,241 Reduced 29.83%	2,919 $236,000
Q3 2023 Oct 24, 2023	BUY	$73.94 - $80.67 $6,728 - $7,340	91 Added 2.24%	4,160 $311,000
Q2 2023 Aug 01, 2023	BUY	$76.01 - $86.7 $30,632 - $34,940	403 Added 10.99%	4,069 $313,000
Q1 2023 May 15, 2023	BUY	$77.31 - $88.08 $283,418 - $322,901	3,666 New	3,666 $304,000
Q2 2022 Aug 08, 2022	SELL	$57.72 - $65.01 $137,662 - $155,048	-2,385 Closed	0 $0
Q1 2022 May 05, 2022	BUY	$57.92 - $72.58 $637 - $798	11 Added 0.46%	2,385 $142,000
Q4 2021 Feb 08, 2022	BUY	$64.88 - $73.64 $38,344 - $43,521	591 Added 33.15%	2,374 $172,000
Q3 2021 Oct 27, 2021	SELL	$67.69 - $73.03 $25,112 - $27,094	-371 Reduced 17.22%	1,783 $124,000
Q2 2021 Jul 21, 2021	BUY	$63.47 - $69.35 $25,388 - $27,739	400 Added 22.81%	2,154 $148,000
Q4 2020 Jan 27, 2021	SELL	$56.65 - $64.55 $46,056 - $52,479	-813 Reduced 31.67%	1,754 $102,000
Q3 2020 Oct 26, 2020	SELL	$62.1 - $78.08 $13,413 - $16,865	-216 Reduced 7.76%	2,567 $162,000
Q2 2020 Aug 04, 2020	SELL	$72.34 - $84.0 $56,859 - $66,024	-786 Reduced 22.02%	2,783 $214,000
Q1 2020 Apr 09, 2020	BUY	$62.63 - $80.22 $38,517 - $49,335	615 Added 20.82%	3,569 $267,000
Q4 2019 Jan 06, 2020	BUY	$61.62 - $67.78 $14,049 - $15,453	228 Added 8.36%	2,954 $192,000
Q3 2019 Oct 16, 2019	BUY	$62.51 - $69.0 $49,132 - $54,234	786 Added 40.52%	2,726 $173,000
Q2 2019 Aug 05, 2019	SELL	$61.87 - $69.38 $24,995 - $28,029	-404 Reduced 17.24%	1,940 $0
Q1 2019 Apr 16, 2019	BUY	$62.53 - $70.05 $16,445 - $18,423	263 Added 12.64%	2,344 $152,000
Q4 2018 Jan 29, 2019	BUY	$60.54 - $79.0 $8,536 - $11,139	141 Added 7.27%	2,081 $130,000
Q2 2018 Aug 10, 2018	SELL	$64.88 - $75.68 $51,904 - $60,544	-800 Reduced 29.2%	1,940 $137,000
Q1 2018 May 07, 2018	BUY	$72.84 - $88.8 $28,626 - $34,898	393 Added 16.74%	2,740 $207,000
Q4 2017 Feb 13, 2018	SELL	$71.15 - $83.52 $28,317 - $33,240	-398 Reduced 14.5%	2,347 $197,000
Q3 2017 Nov 06, 2017	BUY	$72.11 - $85.47 $43,266 - $51,282	600 Added 27.97%	2,745 $222,000
Q2 2017 Aug 11, 2017	BUY	N/A	2,145	2,145 $152,000

Others Institutions Holding GILD

# of Institutions

1,926

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $111B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Simon Quick Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simon Quick Advisors, LLC with notifications on news.

Account

Simon Quick Advisors, LLC Gilead Sciences, Inc. Transaction History